Last C$1.33 CAD
Change Today +0.02 / 1.53%
Volume 9.3K
As of 4:00 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Yves Rosconi B.Sc., L.Pharm., M.B.A.

AgeTotal Calculated CompensationThis person is connected to 44 board members in 4 different organizations across 5 different industries.

See Board Relationships


Mr. Yves Rosconi, B.Sc., Pharm., MBA served as Advisor of Theratechnologies Inc. since December 1, 2010. Mr. Rosconi served as President and Chief Executive Officer of Theratechnologies Inc. since November 1, 2004 until November 30, 2010. Mr. Rosconi served as President and General Manager of Rhone-Poulenc Rorer Canada, Inc. He served as Senior Vice-President and Chief Operating Officer of Aeterna Laboratories in Quebec City before re-joining Aventis in 2001 as Senior ...

Read Full Background

Corporate Headquarters*

1405 du Parc-Technologique Boulevard
Quebec City, Quebec G1P 4P5


Phone: 418-652-8525
Fax: 418-948-9191

Board Members Memberships*

Former Chief Executive Officer and President
Former Director


Universite De Montreal, L'
Ecole des Hautes Etudes Commerciales de Montreal

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AEZ:CN C$1.33 CAD +0.02


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AETERNA ZENTARIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at